![](/img/cover-not-exists.png)
818PPSA doubling time (PSADT) and proximal PSA predict metastasis-free survival (MFS) in men with biochemically recurrent prostate cancer (BRPC) after radical prostatectomy (RP): Implications for patient counseling and clinical trial design
Markowski, M., Chen, Y., Feng, Z., Trock, B., Cullen, J., Suzman, D., Antonarakis, E., Paller, C., Han, M., Partin, A., Eisenberger, M.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx370.035
Date:
September, 2017
File:
PDF, 62 KB
english, 2017